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Abstract
Introduction This study pools data from the UK Intensive Care
National Audit and Research Center (ICNARC) Case Mix
Programme (CMP) to evaluate the case mix, outcome and
activity for 17,326 patients with severe acute kidney injury (AKI)
occurring during the first 24 hours of admission to intensive care
units (ICU).
Methods Severe AKI admissions (defined as serum creatinine
≥300 μmol/l and/or urea ≥40 mmol/l during the first 24 hours)
were extracted from the ICNARC CMP database of 276,326
admissions to UK ICUs from 1995 to 2004. Subgroups of
oliguric and nonoliguric AKI were identified by daily urine output.
Data on surgical status, survival and length of stay were also
collected. Severity of illness scores and mortality prediction
models were compared (UK Acute Physiology and Chronic
Health Evaluation [APACHE] II, Stuivenberg Hospital Acute
Renal Failure [SHARF] T0, SHARF II0 and the Mehta model).
Results Severe AKI occurred in 17,326 out of 276,731
admissions (6.3%). The source of admission was nonsurgical in
83.7%. Sepsis was present in 47.3% and AKI was nonoliguric
in 63.9% of cases. Admission to ICU with severe AKI accounted
for 9.3% of all ICU bed-days. Oliguric AKI was associated with
longer length of stay for survivors and shorter length of stay for
nonsurvivors compared with nonoliguric AKI. Oliguric AKI was
associated with significantly greater ICU and hospital mortality
(55.8% and 77.3%, respectively) compared with nonoliguric
AKI (33.4% and 49.3%, respectively). Surgery during the 1
week before admission or during the first week in the CMP unit
was associated with decreased odds of mortality. UK APACHE
II and the Mehta scores under-predicted the number of deaths,
whereas SHARF T0 and SHARF II0 over-predicted the number
of deaths.
Conclusions Severe AKI accounts for over 9% of all bed-days
in adult, general ICUs, representing a considerable drain on
resources. Although nonoliguric AKI continues to confer a
survival benefit, overall survival from AKI in the ICU and survival
to leave hospital remains poor. The use of APACHE II score
measured during the first 24 hours of ICU stay performs well as
compared with SHARF T0, SHARF II0 and the Mehta score, but
it lacks perfect calibration.
Introduction
Acute kidney injury (AKI) is relatively common in the intensive
care setting and has an associated mortality of 50% to 80%,
which has remained largely unchanged despite advances in
renal replacement therapy (RRT). This has been attributed to
the changing pattern of associated pathology and the patient
population. AKI is gradually becoming a disease of elderly
populations, with the median age increasing from 41 years inPage 1 of 13
(page number not for citation purposes)
AKI: acute kidney injury; APACHE: Acute Physiology and Chronic Health Evaluation; CMP: Case Mix Programme; CMPD: Case Mix Programme Data-
base; CPR: cardiopulmonary resuscitation; ICNARC: Intensive Care National Audit & Research Centre; ICU: intensive care unit; RIFLE: Risk, Injury, 
Failure, Loss of kidney function, End-stage kidney disease; ROC: receiver operating characteristic; RRT: renal replacement therapy; SHARF: Stuiv-
enberg Hospital Acute Renal Failure.
Critical Care    Vol 12 Suppl 1    Kolhe et al.the 1950s to 60.5 and 73 years during the periods from 1980
to 1988 and from 1997 to 1998, respectively [1,2]. Patients
needing RRT frequently require lengthy intensive care treat-
ment and extensive life support [3,4]. They tend to have multi-
ple co-morbidities, which ultimately influence the outcome. A
number of epidemiological studies have been conducted,
using various criteria for definition of AKI, that examined vari-
ous factors that may contribute to mortality [5].
Over the past 25 years, a body of pathophysiological knowl-
edge has been created by intensive care units (ICUs) and that
has enabled advances to be made in the treatment of patients.
At the same time, a series of tools have been designed to eval-
uate, from multiple perspectives, the outcomes obtained.
Through development of several scoring systems, the inten-
sive care physician can grade the severity of illness in the ICU.
The majority of scoring systems focus on mortality as the main
outcome measure. Usually, the ability of a particular score to
predict mortality is acceptable for a patient group as a whole,
but it translates poorly to the individual patient. Heterogeneity
of patient populations in ICUs may be a reason for these short-
comings. Several authors have addressed the performance of
mortality prediction models in subgroups of patients defined
by the same underlying disease or the same cause of intensive
care admission. Over the past 2 decades, a variety of illness
stratification systems have been employed to analyze the
impact that overall co-morbidity has on the outcome of severe
AKI, and it is clear that co-morbidity has a major influence on
mortality in severe AKI [6-9]. Several mortality prediction mod-
els have been developed, both for use in the multidisciplinary
ICU as well as for specific use in AKI patients[6,10-16]. Many
of these have been developed at a single centre and few were
validated outside their original centre.
The Case Mix Programme (CMP) is the national comparative
audit of adult, general critical care units in England, Wales and
Northern Ireland co-ordinated by the Intensive Care National
Audit & Research Centre (ICNARC). The programme collects
information about patients during their first 24 hours of admis-
sion to the ICU, together with length of stay and mortality out-
come data. This study used data from the CMP to describe
case mix, outcome and activity for patients with severe AKI
during the first 24 hours of admission to ICU.
Materials and methods
Case Mix Programme Database
Data were extracted for 276,731 admissions to 170 adult,
general critical care units from the CMP Database (CMPD),
covering the period from December 1995 to January 2004.
Details of the data collection and validation were reported pre-
viously [17].
Selection of cases
The collection of data for the CMP antedated publication and
dissemination of the RIFLE (Risk, Injury, Failure, Loss of kidney
function, End-stage kidney disease) criteria [18]. Admissions
with severe AKI during the first 24 hours after admission to
intensive care were therefore identified as those with a highest
serum creatinine greater than or equal to 300 μmol/l or a high-
est serum urea greater than or equal to 40 mmol/l during the
first 24 hours after admission to the CMP unit, and not previ-
ously requiring chronic RRT. Although the requirement for
chronic RRT (defined as either chronic haemodialysis, chronic
haemofiltration or chronic peritoneal dialysis) must be docu-
mented before admission or at admission to the CMP unit, at
the time of this data collection the CMP did not collect data
concerning acute RRT. Patients requiring acute RRT during
the first 24 hours of admission, who did not achieve the selec-
tion criteria, will not have been included in the analysis. Data in
the CMP were collected during the first 24 hours of intensive
care admission, and therefore do not capture severe AKI
developing after the first 24 hours of intensive care admission.
Subgroups of oliguric AKI and nonoliguric AKI were identified
by their daily urine output. Oliguria was defined as a daily urine
output of less than 400 ml. For admissions staying at least 24
hours in the CMP unit, daily urine output was defined as the
urine output during the first 24 hours after admission. For
patients admitted and staying at least 8 hours and less than 24
hours in the CMP unit, daily urine output was defined as the
urine output for the entire stay divided by the length of stay in
the unit as a fraction of 24 hours. Patients admitted and stay-
ing less than 8 hours in the CMP unit were excluded from both
the oliguric and nonoliguric subgroups because of imprecision
in estimating daily urine output in these patients.
Data
Data were extracted on case mix, outcome and activity as
defined below.
Case mix
Age at admission and sex were extracted. The following phys-
iological variables, selected a priori, were extracted from the
first 24 hours in the CMP unit: highest serum creatinine, high-
est serum urea, lowest serum albumin and lowest haematocrit.
Acute severity was summarized using the Acute Physiology
and Chronic Health Evaluation (APACHE) II Acute Physiology
Score and the APACHE II score. The former encompasses a
weighting for acute physiology (defined by derangement from
the normal range for 12 physiological variables during the first
24 hours of critical care); the latter additionally encompasses
a weighting for age and for a past medical history of specified
serious conditions [19].
Surgical status was defined as either nonsurgical, elective sur-
gery or emergency surgery, based on the source of admission
to the CMP unit and the National Confidential Enquiry into
Patient Outcome and Death classification of surgery, as has
previously been described [17].Page 2 of 13
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Survival data were extracted at discharge from the CMP unit
and at ultimate discharge from hospital.
Activity
Length of stay in the CMP unit was calculated from the dates
and times of admission and discharge. Length of stay in hos-
pital was calculated from the dates of original admission and
ultimate discharge.
Transfers in from another critical care unit were identified as
admissions whose source of admission to the CMP unit was
any critical care unit in the same or another hospital. Readmis-
sions to the unit within the same hospital stay were identified




Variables reflecting case mix, outcome and activity, as defined
above, were summarized for all admissions with severe AKI
during the first 24 hours in the CMP unit, and for the sub-
groups of oliguric and nonoliguric AKI.
Modelling ultimate hospital mortality
The effect of case mix factors on ultimate hospital mortality
was assessed using a multiple logistic regression model. The
variables entered into the model were age, sex, APACHE II
chronic health conditions (excluding chronic RRT), cardiopul-
monary resuscitation (CPR) within 24 hours before admission
to the CMP unit, mechanical ventilation during the first 24
hours after admission to the CMP unit, surgery up to 1 week
before admission to the CMP unit or within 1 week after admis-
sion to and before discharge from the CMP unit, sepsis during
the first 24 hours after admission to the CMP unit, oliguria,
length of hospital stay before admission to the CMP unit, Glas-
gow Coma Scale score, and all of the physiological variables
from the APACHE II model (except serum creatinine) plus
serum albumin.
Sepsis was classified according to the definition proposed by
the American College of Chest Physicians/Society of Critical
Care Medicine Consensus Conference [20] as evidence of
infection plus at least two systemic inflammatory response
syndrome criteria. These definitions were matched as closely
as possible using data available in the CMPD, as has been
described previously [21]. Length of hospital stay before
admission to the CMP unit was identified from the date of
admission to the CMP unit and the date of original admission
to hospital, and was categorized as 0 days (hospital and criti-
cal care unit admission occurred on the same calendar day), 1
day, 2 to 6 days, or 7 or more days. Age and Glasgow Coma
Scale score were modelled as having a linear effect on the log
odds. All other variables were modelled categorically, using
the categories from APACHE II or APACHE III as appropriate
for the physiological variables but fitting new weights to each
category [6,19]. When a variable was present in both
APACHE II and III, the categorization giving the greatest
number of categories was selected. Categories from
APACHE II were used to model temperature, mean arterial
pressure, arterial pH, serum sodium, serum potassium, haema-
tocrit and white blood cell count. Categories from APACHE III
were used to model heart rate, respiratory rate, oxygenation
(either alveolar-arterial oxygen gradient or arterial oxygen ten-
sion, depending on the inspired oxygen level) and serum albu-
min. Before modelling, adjacent categories were collapsed to
ensure that all categories contained at least 50 admissions
(Figure 1). Admissions missing any routinely measured physi-
ological variables (temperature, blood pressure, heart rate or
respiratory rate) were excluded from the modelling. All other
missing physiological values were assumed normal and were
allocated to the category corresponding to zero APACHE II/III
points.
Comparison of existing mortality prediction models
Data from the CMPD were used to approximate, as closely as
possible, three existing published mortality prediction models
for AKI: the two Stuivenberg Hospital Acute Renal Failure
(SHARF) scores, and the model of Mehta and coworkers [22-
24].
The SHARF score should be evaluated at two specific time
points: T0, at the time of diagnosis of AKI (or the time of admis-
sion to the unit if AKI had been diagnosed before admission);
and T48, 48 hours later. The scores consist of weights for age,
albumin and prothrombin time at T0, and indicators of mechan-
ical ventilation and heart failure at the time of scoring (T0 or
T48). The physiology data in the CMPD are collected as worst
values over the first 24 hours after admission to the CMP unit,
and we took these to represent measurements at T0 for albu-
min and prothrombin time, with the recording of a ventilated
respiratory rate during the first 24 hours after admission taken
to represent ventilation at T0. The physiological variables used
to define heart failure in SHARF are not recorded in the CMP,
and so we relied on the use of vasoactive drugs or the clinical
recording of heart failure as a primary or secondary reason for
admission to intensive care or as a condition relevant to the
admission as a proxy for this variable. No information on
mechanical ventilation or heart failure at 48 hours can be
established from CMP data, so we did not attempt to con-
struct the T48 score. The SHARF score takes the form of an
integer score, with higher scores indicating worse prognosis.
A logistic model is used to convert the score to a probability of
hospital mortality. The coefficients for this model were not
reported, but from a graphical representation of the conver-
sion we estimate the mortality equation at T0 to be as follows:
log odds of hospital mortality = 0.0624 × (SHARF T0) – 8.88.
SHARF II is a revision of SHARF. The SHARF II0 score
includes bilirubin, sepsis and hypotension at T0, in addition toPage 3 of 13
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in the definitions as for SHARF T0 also apply to SHARF II0.
The mortality equation for SHARF II0 was estimated to be as
follows: log odds of hospital mortality = 0.0556 × (SHARF II0)
– 2.99.
The Mehta model consists of weights for age, sex, blood urea
nitrogen, creatinine, haematological failure, liver failure, respi-
ratory failure, heart rate and urine output. The patients included
in the development of the Mehta model were all patients
receiving a nephrology consultation for AKI while in the unit or
those transferred to the unit with AKI. Measurements were
taken on the day of the nephrology consultation, or on the first
day in the unit for those transferred in with AKI. The worst val-
ues measured over the first 24 hours in the CMP unit were
used for blood urea nitrogen, creatinine and heart rate. Urine
output was taken to be the total urine output during the first 24
hours in the CMP unit. The physiological definitions of haema-
tological failure and respiratory failure were matched very
closely, with the exceptions that a requirement for platelet
transfusions as an indicator of haematological failure, and ven-
tilator dependence as an indicator of respiratory failure could
not be identified in the CMPD. The definition of liver failure in
the Mehta model is, 'Acute liver failure with elevations in
bilirubin levels (total and direct), AST (asparate aminotrans-
ferase) and ALT (alanine aminotransferase), and alkaline phos-
phatase greater than two times normal, increase in
prothrombin time and INR (international normalized ratio) of >
1.5 (for patients with pre-existing chronic liver disease, docu-
mented evidence of worsened liver function, and presence of
encephalopathy.' The only variables from this definition that
were available in the CMPD were total serum bilirubin and pro-
thrombin time, and no specific cut-offs are identified in the
Mehta model to indicate acute liver failure. We elected to
define acute liver failure as a highest total serum bilirubin
above 100 μmol/l.
For comparison, we also evaluated the mortality probability
from the UK APACHE II model, representing a generic model
for critical care admissions. The models were assessed for dis-
crimination using the area under the receiver operating char-
acteristic (ROC) curve, for calibration by the mortality ratio
(observed over expected deaths), the Hosmer-Lemeshow C-
statistic and Cox's calibration regression; and for overall fit
using the R statistic from Shapiro's Q, representing the geo-
metric mean of the probability assigned to the true outcome
[25-28]. The models were assessed in the subset of admis-
sions for which all three models could be calculated.
All analyses were performed using Stata 8.2 (Stata Corp LP,
College Station, Texas, USA).
Results
Data
Of 276,731 admissions to 170 adult critical care units in the
CMPD, 17,326 (6.3%) were identified as having severe AKI
during the first 24 hours in the unit. Table 1 describes meas-
ures of case mix, outcome and activity for these admissions
and for the oliguric and nonoliguric AKI subgroups.
Case mix
The mean age of all patients admitted with severe AKI was
63.2 years. There was no age difference between patients
with oliguric and nonoliguric AKI. Sixty-six per cent of admitted
patients with AKI were male. The mean APACHE II score was
24.8, as compared with 16.5 for all admissions included in the
CMPD [17]. Oliguria was associated with higher APACHE II
score and Acute Physiology Score. Eighty-four per cent of all
admissions were nonsurgical, and only 16% were surgical
(emergency surgery/elective surgery ratio 1.94/1).
Outcome
Overall mortality in the CMP unit was 43.3%, rising to 58.6%
at ultimate hospital discharge. Mortality was higher for admis-
sions with oliguric AKI (55.8% at unit discharge and 70.3% at
hospital discharge) than for admissions with nonoliguric AKI
(33.4% and 49.3%).
Figure 1
Recoding of APACHE II/III categories for logistic regression model. Recoding performed to eliminate categories containing fewer than 50 admis-
sions in the multiple logistic regression model. Grey cells denote reference categories. APACHE, Acute Physiology and Chronic Health Evaluation.Page 4 of 13
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The median length of stay in the CMP unit was 4.1 days for
survivors and 2.0 days for nonsurvivors. These compare with
median values of 1.7 days and 2.0 days, respectively, for all
admissions included in the CMPD. Patients admitted with
severe AKI during the first 24 hours of intensive care
accounted for 9.3% of all intensive care bed-days in these
units. Median hospital length of stay was 31 days for survivors
and 8 days for nonsurvivors, as compared with 16 days for sur-
vivors and 9 days for nonsurvivors in the CMPD as a whole.
Oliguria was associated with longer lengths of stay for survi-
vors and shorter lengths of stay for nonsurvivors. Eight per
cent of all patients admitted were transferred in from other crit-
ical care units, and 2% were readmitted from within the same
hospital stay. Patients admitted with oliguric AKI were more
likely to be transferred in from another critical care unit than
those with nonoliguric AKI.
Relationship of case mix factors with ultimate hospital 
mortality
Table 2 shows the results of the multiple logistic regression
model. All factors included in the model were significantly
associated with hospital mortality. The following factors were
associated with increased odds of mortality: increasing age,
male sex, presence of past medical history conditions, CPR
during the 24 hours before admission to the CMP unit,
mechanical ventilation during the first 24 hours after admission
to the CMP unit, oliguria, hospital stay of at least 1 week
Table 1
Case mix, outcome and activity for patients with acute kidney injury during the first 24 hours following admission to intensive care
Category Parameter All patients (n = 17,326) Oligurica (n = 5,687) Nonoligurica (n = 10,133)
Case mix Age (years; mean ± SD) 63.2 ± 15.6 63.5 ± 15.0 63.1 ± 15.7
Sex (male; n [%]) 11,511 (66.4) 3,617 (63.6) 6,925 (68.3)
Surgical status (n [%])
Nonsurgical 14,479 (83.7) 5,005 (88.1) 8,125 (80.3)
Elective surgery 961 (5.6) 187 (3.3) 717 (7.1)
Emergency surgery 1,868 (10.8) 487 (8.6) 1,280 (12.6)
Serum parameters (mean ± SD)
Highest serum creatinine (μmol/l) 459 ± 232 502 ± 244 431 ± 216
Highest serum urea (mmol/l) 32.2 ± 27.3 29.5 ± 15.2 33.9 ± 32.3
Lowest serum albumin (g/l) 21.3 ± 7.2 20.5 ± 6.9 21.6 ± 7.2
Lowest haematocrit (%) 28.6 ± 6.4 28.1 ± 6.3 28.8 ± 6.3
APACHE II (mean ± SD)
APSb 20.2 ± 7.0 24.6 ± 6.5 17.9 ± 6.1
Total scoreb 24.8 ± 7.5 29.3 ± 7.0 22.4 ± 6.5
Outcome Mortality (n [%])
CMP unit 7,508 (43.3) 3,176 (55.8) 3,387 (33.4)
Any hospitalc 9,725 (58.6) 3,850 (70.3) 4,770 (49.3)
Activity Length of stay (days; median [IQR])
CMP unit: survivors 4.1 (1.7–10.3) 5.7 (2.1–13.2) 4.0 (1.8–9.8)
CMP unit: nonsurvivors 2.0 (0.8–6.1) 1.7 (0.9–5.0) 3.4 (1.5–8.9)
Any hospitalc: survivors 31 (17–54) 38 (24–62) 29 (16–51)
Any hospitalc: nonsurvivors 8 (3–20) 7 (2–18) 11 (4–23)
Transfers from another ICU (n [%]) 1,355 (7.8) 561 (9.9) 730 (7.2)
Readmissions within hospital stay (n [%]) 388 (2.2) 116 (2.0) 221 (2.2)
aOliguria is defined as urine output < 400 ml/24 hours; admitted patients staying less than 8 hours in the ICU excluded. bAPACHE II exclusions: 
age < 16 years; ICU stay < 8 hours; readmissions within same hospital stay; transfers from another ICU; admissions following coronary artery 
bypass surgery; and admissions for primary burns. cExcluding readmissions within the same hospital stay. APACHE, Acute Physiology and 
Chronic Health Evaluation; APS, Acute Physiology Score; CMP, Case Mix Programme; ICU, intensive care unit; IQR, interquartile range; SD, 
standard deviation.Page 5 of 13
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Effects of case mix factors on ultimate hospital outcome in admissions with acute kidney injury
Case mix factor Deaths (n) n % Adjusted OR (95% CI) P value
Age (years) < 45 817 2,128 38.4 1.48 (1.44–1.52) per 10 year increase < 0.001
45–54 846 1,776 47.6
55–64 1,671 3,086 54.1
65–74 2,991 4,866 61.5
75+ 2,553 3,720 68.6
Sex Female 2,905 5,217 55.7 Reference 0.004
Male 5,973 10,359 57.7 1.13 (1.04–1.22)
Past medical history Absent 7,355 13,298 55.3 Reference < 0.001
Present 1,523 2,278 66.9 1.82 (1.63–2.03)
CPR before admission No 7,679 14,062 54.6 Reference < 0.001
Yes 1,199 1,514 79.2 1.64 (1.41–1.90)
Mechanical ventilation No 2,086 5,250 39.7 Reference < 0.001
Yes 6,792 10,326 65.8 1.93 (1.76–2.12)
Surgery within 1 week of admission No 6,324 10,751 58.8 Reference < 0.001
Yes 2,554 4,825 52.9 0.80 (0.73–0.87)
Sepsis No 4,362 8,207 53.1 Reference < 0.001
Yes 4,516 7,369 61.3 1.14 (1.06–1.21)
Oliguria No 4,766 9,660 49.3 Reference < 0.001
Yes 3,844 5,466 70.3 1.90 (1.75–2.07)
Length of stay before unit admission 0 days 2,451 4,261 57.5 Reference < 0.001
1 day 1,952 3,666 53.2 0.90 (0.81–1.01)
2–6 days 2,269 4,133 54.9 1.00 (0.90–1.12)
7+ days 2,199 3,508 62.7 1.54 (1.38–1.73)
Temperature (°C)a < 32 68 89 76.4 1.96 (1.12–3.40) < 0.001
32–34 399 557 71.6 1.32 (1.05–1.65)
34–36 2,779 4,595 60.5 1.11 (1.01–1.22)
36–38.5 2,918 5,789 50.4 Reference
38.5–39 882 1,680 52.5 0.96 (0.85–1.10)
39–41 1,614 2,595 62.2 1.16 (1.03–1.30)
≥ 41 185 217 85.3 3.35 (2.18–5.15)
Mean arterial pressure (mmHg)a < 50 2,923 3,803 76.9 2.08 (1.80–2.41) < 0.001
50–70 4,164 7,013 59.4 1.45 (1.28–1.65)
70–110 634 1,682 37.7 Reference
110–130 724 1,988 36.4 0.89 (0.77–1.04)
130–160 366 955 38.3 0.94 (0.78–1.13)
≥ 160 48 96 50.0 1.33 (0.83–2.12)Page 6 of 13
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40–50 179 324 55.2 1.14 (0.87–1.50)
50–100 1,229 2,775 44.3 Reference
100–110 1,044 2,085 50.1 1.18 (1.03–1.35)
110–120 1,287 2,408 53.4 1.26 (1.11–1.44)
120–140 2,543 4,251 59.8 1.46 (1.30–1.64)
140–155 1,262 1,878 67.2 1.66 (1.43–1.93)
≥ 155 1,173 1,623 72.3 1.94 (1.66–2.28)
Respiratory rate (breaths/minute)b < 6 403 628 64.2 1.05 (0.85–1.30) 0.001
6–12 1,836 3,509 52.3 1.00 (0.88–1.13)
12–14 1,771 2,867 61.8 1.19 (1.05–1.36)
14–25 1,395 2,397 58.2 Reference
25–35 2,007 3,784 53.0 1.04 (0.92–1.18)
35–40 689 1,109 62.1 1.33 (1.12–1.58)
40–50 608 1,015 59.9 1.16 (0.97–1.39)
≥ 50 135 203 66.5 1.49 (1.05–2.13)
Oxygenation (mmHg; A-aDO2 [FiO2 ≥0.5])b
A-aDO2 (FIO2 ≥ 0.5) < 0.001
< 250 1,238 2,338 53.0 Reference
250–350 1,576 2,540 62.0 1.25 (1.12–1.40)
350–500 1,034 1,453 71.2 1.68 (1.45–1.94)
≥ 500 1,480 1,951 75.9 1.94 (1.69–2.23)
PaO2 (FIO2 < 0.5)
< 50 114 206 55.3 1.10 (0.80–1.53)
50–70 918 1,786 51.4 1.11 (0.98–1.26)
70–80 786 1,637 48.0 1.02 (0.90–1.16)
≥ 80 1,732 3,665 47.3 Reference
Arterial pHa < 7.15 1,380 1,676 82.3 2.13 (1.82–2.49) < 0.001
7.15–7.25 1,871 2,655 70.5 1.63 (1.46–1.83)
7.25–7.33 2,177 3,744 58.1 1.20 (1.09–1.32)
7.33–7.5 3,290 7,156 46.0 Reference
≥ 7.5 160 345 46.4 0.98 (0.76–1.26)
Serum sodium (mmol/l)a < 120 187 326 57.4 1.49 (1.14–1.94) < 0.001
120–130 1,506 2,654 56.7 1.19 (1.07–1.32)
130–150 6,590 11,687 56.4 Reference
150–155 358 537 66.7 1.45 (1.17–1.80)
155–160 153 221 69.2 1.48 (1.06–2.07)
≥ 160 84 151 55.6 0.92 (0.63–1.36)
Serum potassium (mmol/l)a < 2.5 56 110 50.9 0.67 (0.43–1.05) < 0.001
Table 2 (Continued)
Effects of case mix factors on ultimate hospital outcome in admissions with acute kidney injuryPage 7 of 13
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temperature, low mean arterial pressure, extreme heart rate,
extreme respiratory rate, high respiratory rate, high alveolar-
arterial oxygen gradient, low pH, abnormal serum sodium, high
serum potassium, low serum albumin, high haematocrit, low
white blood count, and low Glasgow Coma Scale score. Sur-
gery during the week before admission or during the first week
in the CMP unit was associated with decreased odds of mor-
tality. The presence of sepsis was also associated with, and
was a significant predictor of, higher hospital mortality (61%
versus 53%).
Comparison of existing mortality prediction models
Of the 17,326 patients admitted with severe AKI identified
during the first 24 hours in intensive care, 14,118 (81.5%) had
sufficient data to calculate the SHARF scores, Mehta proba-
bility and UK APACHE II probability; met the inclusion criteria
for all three models; and had data on mortality at hospital dis-
charge. Measures of discrimination, calibration and overall
accuracy for these models are given in Table 3. Figure 2
shows the ROC curves for the three models, and Figure 3
shows calibration plots of observed against predicted
mortality.
2.5–3 302 535 56.4 0.93 (0.75–1.14)
3–3.5 1,106 2,008 55.1 0.91 (0.81–1.02)
3.5–5.5 4,639 8,297 55.9 Reference
5.5–6 1,137 1,858 61.2 1.17 (1.04–1.32)
6–7 1,244 2,028 61.3 1.13 (1.00–1.27)
≥ 7 394 740 53.2 0.79 (0.66–0.95)
Serum albumin (g/l)b < 20 3,544 5,499 64.4 1.21 (1.11–1.33) < 0.001
20–25 1,834 3,356 54.6 1.02 (0.93–1.13)
25–45 3,469 6,635 52.3 Reference
≥ 45 31 86 36.0 0.55 (0.33–0.93)
Haematocrit (%)a < 20 612 1,008 60.7 0.99 (0.84–1.17) 0.011
20–30 4,748 8,536 55.6 0.89 (0.82–0.97)
30–46 3,168 5,473 57.9 Reference
46–50 218 335 65.1 1.28 (0.98–1.68)
≥ 50 132 224 58.9 0.99 (0.71–1.38)
White blood count (×1,000/mm3)a < 1 176 223 78.9 2.52 (1.73–3.67) < 0.001
1–3 506 680 74.4 1.77 (1.44–2.18)
3–15 3,862 7,468 51.7 Reference
15–20 1,756 3,071 57.2 1.11 (1.00–1.23)
20–40 2,278 3,681 61.9 1.21 (1.09–1.33)
≥ 40 300 453 66.2 1.16 (0.91–1.47)
Glasgow Coma Scale scored 3–4 1,596 2,019 79.0 1.07 (1.06–1.08) per decrease of 1 
point
< 0.001
5–12 1,178 1,924 61.2
13–14 1,099 1,880 58.5
15 5,005 9,753 51.3
All of the factors emerged as statistically significant (P < 0.005) in the multiple logistic regression analysis. Exclusions were as follows: 
readmissions within the same hospital stay; admissions with length of ICU stay < 8 hours; admissions of patients aged < 16 years; admissions 
missing age, sex, surgical status, temperature, mean arterial pressure, heart rate or respiratory rate. Admitted patients with missing values for any 
other physiology variables are assumed to be normal and are placed in the reference category. aCategories from APACHE II (reference category 
equivalent to zero APACHE II points) bCategories from APACHE III (reference category equivalent to zero APACHE III points). cPre-sedation 
values used for admissions sedated or paralyzed during the first 24 hours in ICU. A-aDO2, alveolar-arterial oxygen gradient; APACHE, Acute 
Physiology and Chronic Health Evaluation; CI, confidence interval; CPR, cardiopulmonary resuscitation; FiO2, fractional inspired oxygen; ICU, 
intensive care unit; OR, odds ratio.
Table 2 (Continued)
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and the best calibration, although the null hypothesis of per-
fect calibration was strongly rejected (P < 0.001) by both the
Hosmer-Lemeshow test and Cox's calibration regression.
Overall, UK APACHE II and Mehta under-predicted the
number of deaths (mortality ratio > 1), whereas SHARF T0 and
SHARF II0 over-predicted the number of deaths (mortality
ratio < 1). SHARF T0, SHARF II0 and Mehta exhibited very
poor overall fit by Shapiro's Q, with a value of R < 0.5 indicat-
ing a worse fit than would be obtained by predicting a con-
stant mortality probability of 0.5.
Discussion
In this study we describe the demographics, characteristics,
length of stay and outcome of a nationwide cohort of patients
with both dialysis dependent and nondependent severe AKI in
the ICU – the largest such cohort ever described. In contrast
to other studies, in which a major limitation has been lack of
heterogeneity in the study population, the CMP is a national
comparative audit of adult general critical care units in Eng-
land, Wales and Northern Ireland.
Our study has some important limitations. The definition of AKI
we used was that recommended at the time by the UK Renal
Association standards document [18] and roughly corre-
sponds to the 'failure' category in the RIFLE criteria or to stage
3 of the Acute Kidney Injury Network criteria. Caution therefore
must be exercised in extrapolating our results to milder forms
of AKI. Although the CMP captured patients known to be
receiving RRT for chronic irreversible kidney disease at the
time of data collection, it did not capture data concerning pro-
vision of acute RRT during the first 24 hours in ICU, and we
were therefore unable to perform subgroup analysis for
patients receiving RRT. The CMP does not capture pre-ICU
admission baseline serum creatinine values, and it is conceiv-
able that a few patients might have had very advanced chronic
kidney disease but were not yet receiving chronic RRT, as
opposed to severe AKI. As with any large database, the CMPD
is not immune to missing data. In the CMPD, 2% of the physi-
ological data were missing and this was assumed normal, but
the fact that ICU patients who generate missing values in
observational studies are more likely to less severely ill and
have better outcomes is well established [19]. Finally, in eval-
uating the SHARF scores we used the use of vasoactive drugs
as a surrogate for heart failure, and it is possible that patients
receiving noradrenaline for severe sepsis were misclassified
Table 3
Measures of discrimination, calibration and model fit for SHARF T0, Mehta and UK APACHE II
SHARF T0 SHARF II0 Mehta UK APACHE II
Discrimination (AUC [95% CI]) 0.632 (0.624–0.640) 0.668 (0.660–0.676) 0.693 (0.686–0.701) 0.74 (0.733–0.748)
Calibration (mortality ratio [95% CI]) 0.759 (0.747–0.771) 0.950 (0.936–0.965) 1.223 (1.205–1.242) 1.147 (1.129–1.165)
Hosmer-Lemeshow (C-statistic [P value]) 20,894 (< 0.001) 2,575 (< 0.001) 2,170 (< 0.001) 575 (< 0.001)
Cox's regression calibration:
Slope (95% CI) 0.247 (0.229–0.266) 0.415 (0.390–0.439) 0.444 (0.417–0.470) 0.753 (0.720–0.787)
Intercept (95% CI) -0.195 (-0.243 to -0.153) 0.005 (-0.031 to -0.040) 0.314 (0.278–0.350) 0.306 (0.269–0.343)
χ2 (1) (P value)a 11,598 (< 0.001) 2,303 (< 0.001) 2,602 (< 0.001) 596 (< 0.001)
Fit (Shapiro's Q [R statistic]) 0.392 0.491 0.487 0.539
aChi-squared statistic on one degree of freedom (and associated P value) from a likelihood ratio test of slope = 1, intercept = 0 in Cox's 
regression calibration model. APACHE, Acute Physiology and Chronic Health Evaluation; AUC, area under the receiver operating characteristic 
curve; CI, confidence interval; SHARF, Stuivenberg Hospital Acute Renal Failure.
Figure 2
ROC curves for SHARF T0, SHARF II0, Mehta and UK APACHE II. 
APACHE, Acute Physiology and Chronic Health Evaluation; SHARF, 
Stuivenberg Hospital Acute Renal Failure.Page 9 of 13
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regarding the validity of the SHARF scores.
We found the prevalence of severe AKI to be 6.3% of all ICU
admissions. This is keeping with the prevalence of 5.73%
reported by Lins and coworkers [22]. Other studies have
found a similar prevalence of severe AKI in ICU using a defini-
tion similar to the one that we used [29-31].
Part of the basis for the RIFLE classification of AKI was that
even mild impairment in renal function has an impact on mor-
tality. Unsurprisingly, studies using the RIFLE criteria therefore
report a higher overall prevalence of AKI. Hoste and coworkers
[31] recently reported an overall prevalence of AKI of 67.2%;
limiting cases to those with RIFLE class F reduced this to
28%. Others have reported lower figures. Ostermann and col-
leagues [5] found the overall incidence of AKI to be 35.8%,
whereas Uchino and coworkers [32] found the incidence of
AKI to be 14.7%. AKI is a dynamic process, and patients may
progress from 'risk' to 'injury' to 'failure'. Although Ostermann
and colleagues had more patients in the 'risk' class, Hoste and
coworkers found that more than 50% of their 'risk' patients
had progressed to 'injury' or to 'failure'. The variability in the
incidence of AKI, even using the same definition of AKI, can be
partly attributed to the different case mix of patients in ICU in
Northern America, Australia and the UK.
The mean age of admitted patients in the present study was
63.2 years, and this is similar to that identified in many other
studies of AKI in the ICU, indicating that AKI is gradually
becoming a disease of the elderly population [5,9,33,34]
Although Mehta and coworkers [23] reported a surgical pre-
dominance of causes of AKI (63.1%), the aetiology of AKI in
the adult, general ICU has become predominantly nonsurgical
and ranges from 65% to 85% of all admissions [29,35].
In our study, the ICU mortality of severe AKI was 43.3%,
increasing to 58.6% at the time of hospital discharge. It is
important to appreciate that mortality in all classes of AKI is
increased even after discharge from ICU, and hospital mortal-
ity is therefore a more accurate reflection of the outcome from
AKI in the ICU. In another UK study, Abosaif and coworkers
[36] applied the RIFLE classification retrospectively to their
ICU patients and found an ICU mortality of 74.5% in the 'fail-
Figure 3
Calibration plots for SHARF T0, SHARF II0, Mehta and UK APACHE II. Observed mortality plotted against deciles of predicted mortality. Diagonal 
line indicates perfect calibration. APACHE, Acute Physiology and Chronic Health Evaluation; SHARF, Stuivenberg Hospital Acute Renal Failure.Page 10 of 13
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47.5%. Hoste and colleagues [31] reported a gradual
increase in mortality in different classes of AKI, with an ICU
mortality of 26.3% in patients with the 'failure' class of AKI.
Åhlström and coworkers [37] found a mortality of 23% in the
'failure' class of AKI. A recent study [30] investigated the epi-
demiology of all AKI in the ICU in 54 study centres, irrespec-
tive of RRT requirement. The authors reported an ICU mortality
of 52% and a hospital mortality of 60.3%.
AKI patients tend to be sicker, have multiple co-morbidities
and require longer ICU stay compared with patients without
AKI. In the present study, the presence of severe AKI
increased both the median length of ICU and hospital stay.
The presence of oliguria further prolonged the length of ICU
and hospital stay.
The presence of oliguria has long been considered a negative
predictor of patient survival and a factor associated with
delayed renal recovery [7,13,38,39]. However, strategies aim-
ing to convert oliguric states to nonoliguric states have not
been successful in terms of improving outcomes [40,41]. In
the present study the median length of ICU stay for oliguric
AKI survivors was increased in comparison with that in nono-
liguric AKI survivors. The outcome was also significantly
poorer, with both ICU and hospital mortality considerably
worse for oliguric AKI than for nonoliguric AKI. Oliguric
patients generally tend to have more advanced AKI, and in our
study we found these patients to have a higher APACHE II
score (29.3 versus 22.4).
We investigated the effects of case mix factors on ultimate
hospital outcome in this large cohort of patients with severe
AKI. Increasing age was found to be a negative predictor of
survival. Several studies have also identified age as an adverse
prognostic factor in AKI, whereas others have not found this
association [5,13,16,19,32,42]. With increasing age the
number of co-morbidities increases, and this can have delete-
rious effects on survival. Increasing length of stay before
admission to ICU (> 7 days) was associated with increased
risk for death in the present study. Brivet and coworkers [35]
found a hospital mortality of 50% in patients admitted directly
to ICU, in contrast to 66% for patients transferred to ICU from
within the hospital. Multiple and increasing organ dysfunction
before ICU transfer was the probable cause. Studies have
shown that 'isolated AKI' occurring as a result of contrast
nephropathy due to routine radiological procedures has a
much lower mortality [8,9]. Proven or suspected sepsis was
predictive of death in several studies [7,30,35,43] and this too
was the case in our study. As with previous studies, hypoten-
sion and need for mechanical ventilation were also predictors
of death in our study [5,13,16,39,44,45].
Many studies have attempted to find the best possible severity
of illness scoring system, but each scoring system developed
has been limited by the lack of heterogeneity in the population
studied and/or development of the scoring system based on
findings from a single centre study [23,36,37,39,46,47]. In
addition, severity of illness scores have been applied at differ-
ent time frames within the ICU stay, for example at admission
to ICU, within 24 hours of admission to ICU and at the initiation
of RRT. A particular goal for any of the severity of illness scores
in AKI should be to identify patients for whom RRT will be futile
because of 100% mortality despite dialysis. In this large study,
we estimated the conventional severity of illness risk score
commonly used in the UK (APACHE II) and compared the area
under the ROC curve with that for the SHARF T0, SHARF II0
and Mehta severity of illness scores. We found the area under
the ROC curve to be best for APACHE II (0.740), but it over-
predicted death (mortality ratio > 1). The area under the ROC
curve for the Mehta, SHARF T0 and SHARF II0 scores was
0.693, 0.632 and 0.668, respectively, and all of them under-
predicted death, although SHARF II0 performed better than
SHARF T0. Douma and coworkers [46] compared 11 differ-
ent mortality prediction models in ICU patients with dialysis-
dependent AKI and reported good performance of the
APACHE III and Liano models (area under the ROC curve of
0.74 and 0.78, respectively). In contrast, Lins and coworkers
[22] found the ROC values of the Liano model and APACHE
II to be lower than that of the SHARF T0 (0.82) scores. The
SHARF score, developed in a single-centre study, was found
to be less precise when tested in new and different multicentre
ICU cohorts (area under the ROC curve values of 0.67 and
0.78 at 0 and 48 hours in multicentre cohorts, respectively,
versus 0.87 and 0.9 in the original single centre cohort). Lins
and coworkers [24] reanalyzed the multicentre data after add-
ing three more variables in the modified SHARF II score and
demonstrated improved discrimination (area under the ROC
curve values of 0.82 and 0.83 at 0 and 48 hours, respectively).
Abosaif and coworkers [36] found that the Simplified Acute
Physiology Score II and the APACHE II score were more reli-
able in patients with either the 'risk' or 'injury' RIFLE classes
than for the 'failure' class. Åhlström and coworkers [37] found
that the Sequential Organ Failure Assessment score (area
under the AUC curve 0.725) performed better than APACHE
II score (area under the AUC curve 0.703). Chertow and cow-
orkers [39] compared their PICARD (Program to Improve
Care in Acute Renal Disease) model with eight generic and
three AKI-specific scores at three different time points: AKI
diagnosis, the day of consultation and the day of first proce-
dure. Among the generic models, they found that the Sequen-
tial Organ Failure Assessment score performed the best when
applied at the two later points. The Cleveland Clinic Founda-
tion score performed best among patients requiring RRT
So what can we conclude then about severity of illness scores
in ICU patients with AKI? To date no AKI-specific severity of
illness scoring method has exhibited excellent predictive
power for mortality. There could be several reasons for this.Page 11 of 13
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with increasing severity of AKI. At present there is no consen-
sus regarding the timing of application of mortality prediction
scores. The various mortality prediction scores have been
developed using different definitions of AKI.
In the present study the UK APACHE II model exhibited the
best discrimination and the best calibration, although the null
hypothesis of perfect calibration was strongly rejected. The
Mehta score under-predicted mortality (ratio > 1). Although
possibly influenced by an inaccurate definition of heart failure,
the SHARF T0 and SHARF II0 over-predicted mortality (ratio
< 1). However, even this caveat could not possibly account for
the large deficit in discrimination, perhaps serving to illustrate
that specific models derived in small groups of patients are
unlikely to outperform general models derived in large cohorts.
Conclusion
The results of the present study confirm that severe AKI in ICU
patients presents an excess risk for ICU and in-hospital mor-
tality, and doubles ICU and hospital lengths of stay, irrespec-
tive of the requirement for RRT. Patients with severe AKI in the
ICU accounted for 9.3% of all ICU bed-days, and these figures
provide a basis for an estimation of the minimum service
required to provide ICU services for the treatment of severe
AKI and the potential associated costs. Patients with oliguric
AKI had even worse mortality, and those surviving had even
longer lengths of ICU and hospital stay.
The aetiology of ICU severe AKI in the UK is predominantly
nonsurgical, and the mean age of ICU AKI in the UK is increas-
ing. Increasing age; past medical history; CPR; mechanical
ventilation; sepsis; oliguria; length of stay more than 7 days
before ICU admission; extremes of mean arterial pressure,
heart rate, respiratory rate and temperature; and low pH all
predict increased mortality. Surgery within 1 week of ICU
admission conferred a survival benefit. Finally, although sever-
ity of illness scores were worse in nonsurvivors than in survi-
vors, no score reliably predicted mortality. The use of APACHE
II score measured during the first 24 hours of ICU stay per-
forms well as compared with the SHARF T0, SHARF II0 and
Mehta scores, but it lacks perfect calibration.
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